All stock lists
Unlock the score
Apnimed, Inc. (NASDAQ:APMD)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
18.95-0.04 (-0.21%)
Insider Score
/ 100
APMD Insider Score
Apnimed, Inc. has a live Insider Score.
Scored on 1 qualifying trade from 1 insider in the last 90 days.
APMD Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 12.08 M | 84.81 M | 17.11 M | 3.13 M |
| Revenue Growth (YoY) | — | — | — | — |
| Cost of Revenue | 1.21 M | 2.16 M | 1.72 M | 1.32 M |
| Gross Profit | 10.87 M | 82.65 M | 15.39 M | 1.81 M |
| SG&A Expense | 12.67 M | 6.51 M | 5.35 M | 5.47 M |
| R&D Expense | 9.90 M | 8.10 M | 15.97 M | 23.46 M |
| Operating Expenses | 22.57 M | 14.61 M | 21.32 M | 28.93 M |
| Operating Income | -11.70 M | 68.04 M | -5.94 M | -27.11 M |
| Pretax Income | 126.11 M | 70.37 M | -5.63 M | -26.68 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | 125.94 M | 70.37 M | -69.47 M | -28.65 M |
| EPS (Basic) | 3.16 | 2.45 | -2.42 | -1.00 |
| EPS (Diluted) | 3.16 | 2.12 | -2.42 | -1.00 |
| Shares Outstanding | 39.82 M | 28.76 M | 28.76 M | 28.76 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.